BILL · 2011–12 SESSION
SB 5229: Atypical antipsychotic drugs
Creating an exemption from preferred drug substitution for atypical antipsychotic drugs.
Summary
- Exempts prescriptions for atypical antipsychotic drugs from preferred drug substitution.
From the Bill Digest (SB 5229), written by the Legislature's nonpartisan staff. Read the full report ↗
Did not pass Did not pass · died in committee
- IntroducedJan 18, 2011
- Out of committeestopped here
- Passed Senate
- Passed House
- Governor
- Law
- Prime sponsor
- Steve Hobbs (D-44)
- Introduced
- January 18, 2011 in the Senate
- Last action
- April 11, 2012
- Companion bill
- HB 1396
AN ACT Relating to creating an exemption from preferred drug substitution for atypical antipsychotic drugs;
Sponsors
Prime sponsor: Steve Hobbs (D-44)
5 co-sponsors (2 Democrats, 3 Republicans)
Votes
No recorded floor votes. This measure never reached a floor vote.
History
- By resolution, reintroduced and retained in present status.
- By resolution, reintroduced and retained in present status.
- By resolution, reintroduced and retained in present status.
- By resolution, reintroduced and retained in present status.
- By resolution, reintroduced and retained in present status.
- First reading, referred to Health & Long-Term Care.
SB 5229 in other sessions
Bill numbers restart every two years, so the same number is a different bill in each session.
- SB 5229 (2025–26) Opioid overdose/civil commit
- SB 5229 (2023–24) Site readiness grants
- SB 5229 (2021–22) Health equity continuing ed.
- SB 5229 (2019–20) Presidential primary
- SB 5229 (2017–18) Movie theaters/beer & wine
- SB 5229 (2015–16) Technology literacy
- SB 5229 (2013–14) Alcohol and drug violators
- SB 5229 (2009–10) Legislative youth adv counc